Overall verdict
Neutral
4.4/10
1-year performance
+20.13%
Score breakdown
Up 20.1% over 1 year, 90% of the 52-week range.
Strongest: Financial strength 2.6/10. Weakest: Growth 1.0/10.
24 analysts, target +0.1% vs the price.
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products.
It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research ; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments.
In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Sector
Health Care
Industry
Life Sciences Tools and Services
Primary listing
Nyse
United States
CEO
Udit Batra
Founded
1958
Employees
7 900
Revenue / employee
400 669 USD
Next earnings
February 9, 2027 (estimated)
Institutional holders
- FMR LLC3.81%
- GEODE CAPITAL MANAGEMENT, LLC2.70%
- Bank of New York Mellon Corp0.51%
- Rest of the register92.98%
3 13F filings as of September 30, 2026: US managers above $100M, filed up to 45 days after quarter end. No insiders, no retail. A share on loan is declared by its lender and by whoever bought it from the short seller, so the total can exceed 100%.
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
483.33 USD
52-week low
282.77 USD
1-year performance
20.13%
Rising
Year-to-date performance
22.15%
Rising
Drawdown
-4.18%
Near its high
Position in the 52-week range
90% of range
Against the world ETF
Over 26 years, from December 2000 to October 2026, the share did not clearly beat the world ETF once risk is accounted for. It earned less, while shaking 2.1 times harder.
$10,000 placed at the end of December 2000 are worth today
| Waters | $55,416 |
| World ETF | $65,117 |
| S&P 500 | $91,204 |
| Risk-free placement | $15,894 |
The risk
- Shaking:the share moves 2.1 times as much as the world ETF.
- Worst fall:-75 % between December 2000 and March 2003. $10,000 placed at the top fell to $2,534. The world ETF, at worst: -53 %. Back to its high in 96 months.
Waters earned less than the world ETF since 2000
Value of $10,000 placed at the end of December 2000, dividends reinvested, in dollars
- Waters: $55,416
- World ETF: $65,117
- S&P 500: $91,204
- Risk-free placement: $15,894
Based on past performance. This is not a recommendation.
Gross margin 38.0%, net margin 1.8%, ROIC 0.8%, ROE 1.1%.
Net margin
1.75%
Low
Sector 4.51%|S&P 13.40%
Gross margin
37.98%
Fair
Return on equity (ROE)
1.11%
Low
Sector 3.57%|S&P 17.06%
Return on invested capital (ROIC)
0.83%
Low
Free cash flow margin (FCF)
4.76%
Low
Profit-to-cash conversion (FCF conversion)
2.72x
Exceptional
Margin stability
6.8 pts
Uneven
Revenue to net income
Growth
1.0/10Revenue up 120.9% over 1 year, 6.0% a year over 5, EPS 5.2% a year over 5.
Revenue (trailing 12 months)
5.6Md USD
Revenue growth (1y)
120.91%
Hyper-growth
Revenue growth (3y)
6.51%
Moderate
EPS growth (1y)
-67.13%
Declining
EPS CAGR (5y)
5.19%
Low
EPS revisions (3 months)
0.67%
Revised up
Valuation
2.4/10P/E 198.9x, forward P/E 134.1x, EV/EBITDA 41.1x, PEG 38.31. The multiple sits in the 100th percentile of its own 5-year history.
P/E (TTM)
198.9x
Very expensive
Sector 46.3x|S&P 23.6x
Forward P/E
134.1x
Fair
EV / EBITDA
41.1x
Expensive
Sector 22.4x|S&P 15.5x
PEG
38.31
Very expensive
Sector 1.25|S&P 0.91
P/E vs its own 5-year history
among the 1% highest valuations
At its historical high
Market cap
45.5Md USD
Financial strength
2.6/10Cash covers 11.6% of the debt, net debt/EBITDA 0.8x.
Net debt / EBITDA
0.8x
Stretched
Gearing (net debt / equity)
29.69%
Very solid
Cash
593M USD
Cash / market cap
1.30%
Stretched
Cash / total debt
11.55%
Stretched
Interest coverage
1.5x
Stretched
Net debt
4.5Md USD
Equity
15.3Md USD
Closed daily candles, 2 years
Last close on November 11, 2026: 470.90 USD
- MM20459.00
- MM50438.27
- MM200372.39
- RSI 1458.3
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
+1.91%
200-day average slope, 3 months
+4.28%
50-day average slope, 1 month
+4.83%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
2.09 % per day
Volatility change
+4.56%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 3.45 (4) | 14.67 (23) | 6 491 (21) | 2 136 (14) | 445 (4) |
| 2027 | 11.25 (10) | 16.53 (24) | 7 166 (23) | 2 412 (14) | 1 052 (8) |
Amounts in millions of USD, EPS in USD per share. In brackets, the number of analysts. Consensus as of November 4, 2026.
Same sub-industry: 104 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 603259 | 8.7 | 8.2 | 68.4Md USD | — | — | 70.5 % | — | -1.7x | — | 62.1 % | ||
| 2 | IQV | 7.3 | 6.9 | 45.2Md USD | 33.4x | 8.1 % | 8.0 % | 6.8 % | 4.1x | 4.6 % | 28.0 % | ||
| 3 | A207940 | 7.1 | 7.0 | 52.5Md USD | 39.7x | 41.1 % | -10.2 % | — | -0.2x | — | -24.4 % | ||
| 4 | A | 6.5 | 6.0 | 49.9Md USD | 34.8x | 19.5 % | 8.1 % | 13.9 % | 0.9x | 2.5 % | 20.4 % | ||
| 5 | DHR | 6.5 | 6.4 | 166Md USD | 38.5x | 16.7 % | 8.3 % | 5.9 % | 2.0x | 3.5 % | 11.5 % | ||
| 6 | TMO | 6.2 | 5.5 | 266Md USD | 37.9x | 14.9 % | 9.1 % | 8.0 % | 2.8x | 2.9 % | 24.6 % | ||
| 7 | LONN | 5.6 | 4.7 | 54.1Md USD | Not meaningful (loss) | 16.7 % | 19.2 % | 8.7 % | 1.9x | 0.5 % | 22.7 % | ||
| 8 | MTD | 5.3 | 4.9 | 34.8Md USD | 37.9x | 22.2 % | 6.3 % | 47.4 % | 1.8x | 2.5 % | 21.0 % | ||
| 9 | WAT | 4.4 | 1.9 | 45.5Md USD | 198.9x | 1.8 % | 120.9 % | 0.8 % | 0.8x | 0.6 % | 20.1 % |
